HZNP
Vanguard Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-21,587,441
| Closed | -$2.5B | – | 4604 |
|
|
2023
Q3 | $2.5B | Buy |
21,587,441
+42,917
| +0.2% | +$4.97M | 0.06% | 330 |
|
|
2023
Q2 | $2.22B | Sell |
21,544,524
-8,709
| -0% | -$896K | 0.05% | 381 |
|
|
2023
Q1 | $2.35B | Buy |
21,553,233
+317,130
| +1% | +$34.6M | 0.06% | 352 |
|
|
2022
Q4 | $2.42B | Sell |
21,236,103
-40,559
| -0.2% | -$4.62M | 0.07% | 325 |
|
|
2022
Q3 | $1.32B | Buy |
21,276,662
+354,287
| +2% | +$21.9M | 0.04% | 468 |
|
|
2022
Q2 | $1.67B | Buy |
20,922,375
+593,498
| +3% | +$47.3M | 0.05% | 418 |
|
|
2022
Q1 | $2.14B | Buy |
20,328,877
+190,183
| +0.9% | +$20M | 0.05% | 401 |
|
|
2021
Q4 | $2.17B | Buy |
20,138,694
+113,681
| +0.6% | +$12.3M | 0.05% | 413 |
|
|
2021
Q3 | $2.19B | Buy |
20,025,013
+98,861
| +0.5% | +$10.8M | 0.05% | 383 |
|
|
2021
Q2 | $1.87B | Sell |
19,926,152
-578,245
| -3% | -$54.1M | 0.05% | 445 |
|
|
2021
Q1 | $1.89B | Buy |
20,504,397
+584,139
| +3% | +$53.8M | 0.05% | 410 |
|
|
2020
Q4 | $1.46B | Buy |
19,920,258
+667,408
| +3% | +$48.8M | 0.04% | 462 |
|
|
2020
Q3 | $1.5B | Buy |
19,252,850
+1,498,315
| +8% | +$116M | 0.05% | 402 |
|
|
2020
Q2 | $987M | Buy |
17,754,535
+209,759
| +1% | +$11.7M | 0.04% | 508 |
|
|
2020
Q1 | $520M | Buy |
17,544,776
+455,362
| +3% | +$13.5M | 0.02% | 653 |
|
|
2019
Q4 | $619M | Buy |
17,089,414
+91,470
| +0.5% | +$3.31M | 0.02% | 727 |
|
|
2019
Q3 | $463M | Buy |
16,997,944
+403,816
| +2% | +$11M | 0.02% | 831 |
|
|
2019
Q2 | $399M | Sell |
16,594,128
-287,091
| -2% | -$6.91M | 0.02% | 909 |
|
|
2019
Q1 | $446M | Buy |
16,881,219
+1,515,341
| +10% | +$40.1M | 0.02% | 844 |
|
|
2018
Q4 | $300M | Buy |
15,365,878
+552,037
| +4% | +$10.8M | 0.01% | 983 |
|
|
2018
Q3 | $290M | Buy |
14,813,841
+547,099
| +4% | +$10.7M | 0.01% | 1140 |
|
|
2018
Q2 | $236M | Buy |
14,266,742
+617,818
| +5% | +$10.2M | 0.01% | 1242 |
|
|
2018
Q1 | $194M | Buy |
13,648,924
+173,831
| +1% | +$2.47M | 0.01% | 1308 |
|
|
2017
Q4 | $197M | Buy |
13,475,093
+297,663
| +2% | +$4.35M | 0.01% | 1310 |
|
|
2017
Q3 | $167M | Buy |
13,177,430
+194,712
| +1% | +$2.47M | 0.01% | 1398 |
|
|
2017
Q2 | $154M | Buy |
12,982,718
+233,443
| +2% | +$2.77M | 0.01% | 1406 |
|
|
2017
Q1 | $188M | Buy |
12,749,275
+506,596
| +4% | +$7.49M | 0.01% | 1260 |
|
|
2016
Q4 | $198M | Buy |
12,242,679
+353,805
| +3% | +$5.72M | 0.01% | 1173 |
|
|
2016
Q3 | $216M | Buy |
11,888,874
+1,319,697
| +12% | +$23.9M | 0.01% | 1063 |
|
|
2016
Q2 | $174M | Buy |
10,569,177
+737,812
| +8% | +$12.2M | 0.01% | 1136 |
|
|
2016
Q1 | $163M | Buy |
9,831,365
+263,703
| +3% | +$4.37M | 0.01% | 1145 |
|
|
2015
Q4 | $207M | Buy |
9,567,662
+643,131
| +7% | +$13.9M | 0.01% | 978 |
|
|
2015
Q3 | $177M | Buy |
8,924,531
+328,622
| +4% | +$6.51M | 0.01% | 1068 |
|
|
2015
Q2 | $299M | Buy |
8,595,909
+3,088,983
| +56% | +$107M | 0.02% | 819 |
|
|
2015
Q1 | $143M | Buy |
5,506,926
+1,502,079
| +38% | +$39M | 0.01% | 1253 |
|
|
2014
Q4 | $51.6M | Buy |
4,004,847
+2,241,340
| +127% | +$28.9M | ﹤0.01% | 1816 |
|
|
2014
Q3 | $21.7M | Buy |
1,763,507
+88,791
| +5% | +$1.09M | ﹤0.01% | 2173 |
|
|
2014
Q2 | $26.5M | Buy |
1,674,716
+419,993
| +33% | +$6.64M | ﹤0.01% | 2107 |
|
|
2014
Q1 | $19M | Buy |
1,254,723
+275,879
| +28% | +$4.17M | ﹤0.01% | 2206 |
|
|
2013
Q4 | $7.46M | Buy |
978,844
+114,248
| +13% | +$871K | ﹤0.01% | 2585 |
|
|
2013
Q3 | $2.92M | Buy |
864,596
+104,740
| +14% | +$354K | ﹤0.01% | 2986 |
|
|
2013
Q2 | $1.87M | Buy |
+759,856
| New | +$1.87M | ﹤0.01% | 3086 |
|